4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000102
Senior Vice President, Finance sold 533 shares at $95.75 ($51,035)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Agarwal Arjun Senior Vice President, Finance | 2026-09-21 | Sale 10b5-1 | −533 | $95.75 | $51,035 | 14,219 | D |
| Open-market sales · 533 sh · avg $95.75 · $51,035 | |||||||
Loading xslF345X06/form4.xml…